-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Acorda Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2014 to 2023.
- Acorda Therapeutics, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $39.9M, a 18.3% increase year-over-year.
- Acorda Therapeutics, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $389M, a 162% increase year-over-year.
- Acorda Therapeutics, Inc. annual Costs and Expenses for 2023 was $383M, a 149% increase from 2022.
- Acorda Therapeutics, Inc. annual Costs and Expenses for 2022 was $154M, a 26% decline from 2021.
- Acorda Therapeutics, Inc. annual Costs and Expenses for 2021 was $208M, a 9.93% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)